Tocqueville Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Tocqueville Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-55,000	Closed	-$303K	–	873
2016 Q3	$303K	Hold	55,000	–	–	﹤0.01%	711
2016 Q2	$209K	Hold	55,000	–	–	﹤0.01%	790
2016 Q1	$152K	Hold	55,000	–	–	﹤0.01%	818
2015 Q4	$312K	Sell	55,000 -25,000	-31%	-$152K	﹤0.01%	759
2015 Q3	$424K	Buy	80,000 +45,000	+129%	+$348K	0.01%	745
2015 Q2	$291K	Buy	+35,000	New	+$170K	﹤0.01%	839

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Tocqueville Asset Management's SGYP Position: Q4 2016 in Review

Tocqueville Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 55,000 shares — an estimated $303K sold.

Tocqueville Asset Management first reported a position in SGYP in Q2 2015 and held it in 6 quarters. The position peaked at $424K in Q3 2015. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

Tocqueville Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 55,000 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $303K.
Tocqueville Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 6 quarters.
Tocqueville Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $424K in Q3 2015.
156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.